Skip to main content

ChromaDex to Participate in the LD Micro Invitational XIII

ChromaDex Corp. (NASDAQ:CDXC) today announced that it will be participating at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings.

ChromaDex’s Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, are scheduled to present on June 6th at 1:30pm Pacific Time (4:30pm Eastern Time).

ChromaDex management will also attend virtual one-on-one meetings with institutional investors throughout the day. For those interested in having a meeting with ChromaDex, please visit for more information.

We invite interested parties to watch ChromaDex’s live presentation via this webcast link: ChromaDex Investor Presentation – LD Micro Invitational

To view ChromaDex’s profile, please use this link:

For additional information on ChromaDex, visit

About ChromaDex:

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex maintains a website at to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.

ChromaDex to Participate in the LD Micro Invitational XIII


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.